ACTIVITY

The various souls that CHARTA Foundation has within itself can satisfy various necessities of the companies operating in health and social care industry.

Among the main scientific activities there are:
– Health Technology Assessment – HTA;
– real world evidence studies;
– administrative database studies;
– economic-health analysis (cost-efficacy, cost-utility, etc.) led through the creation of analytical and decision-making models or through the use of data from observational studies or clinical trials;
– burden of disease studies;

– assessment of patients reported outcomes, such as studies on quality of life;
– Discrete Choice experiment.

Among the activities of strategic support there are:
– market access;
– creation of value dossier;
– relationships with institutions and scientific societies;
– analysis of changes in national and regional health care systems
– institutional monitoring and stakeholder mapping
– legal advice on procurements.

The activities of communication include:

– training courses and ECM courses;
– organization of boards;
– events in whether or not institutional venues;
– launches of products and new brands;
– activities of press office;
– social campaigns;
– realization of short videos;
– realization of special graphics.

Scientific

ACTIVITIES

The scientific activities led by CHARTA Foundation have as purpose the production of evidences having a direct impact on clinical practice, health of people and health care policies, both region-wide and nationwide. In order to achieve said purpose, we have created a team of experts in various areas such as health economics, medical statistics, analytical and decision-making models and analysis of patients reported outcomes.

Our therapeutic areas of specialization include:

Rare diseases (Haemophilia, Thalassaemia, MPS, Hereditary Angioedema, Behçet’s Syndrome etc.)
Cardiac-metabolic (coronary heart diseases, peripheral vascular diseases, brain vascular diseases, Diabetes, Atrial Fibrillation, chronic kidney disease, venous thromboembolism, Hypertension, etc.)
Autoimmune diseases (Rheumatoid Arthritis, Psoriatic Arthritis, Crohn’s disease, ulcerous Colitis, etc.)
Vaccines (Pneumococcal conjugate vaccine, human Papillomavirus)

Neurological and psychiatric disorders (Parkinson’s disease, Alzheimer’s disease, Depression, Schizophrenia

Infectious Diseases (Hepatitis C, Hepatitis B, HIV, urinary tract Infections)

Respiratory diseases (Chronic obstructive pulmonary disease, Idiopathic Pulmonary Fibrosis)

Oncology (Pulmonary Carcinoma, Colon-Rectal Carcinoma, Kidney Carcinoma, Multiple Myeloma, Hepatocellular Carcinoma, Breast Carcinoma, Prostatic Carcinoma, Chronic Lymphocytic Leukemia…)

Among the activities we perform in social and health care area:

Assessment of the economic efficiency of pharmacological therapies through the determination of cost/efficacy, cost/utility and cost/benefit ratios

Disease cost analysis
Economic assessments for regulatory purposes (pre-marketing assessment)
Perspective and retrospective, descriptive and comparative assessments (post-marketing assessment)
Drug-use analysis
Assessments of epidemiology of healthcare
Analysis on clinical and administrative databases
Studies of Patients Reported Outcomes: Quality of Life Linked to the Health Condition, Treatment Satisfaction, elicitation of preferences and Willingness To Pay (through the application of methods as Discrete Choice Experiments)
Development and validation of tools of Patients Reported Outcomes

Activities of

STRATEGIC SUPPORT

Among the activities of strategic support that CHARTA offers to the companies there are those related to the Institutional Relationships, Market Access and activities of Legal Advice on Procurements.

Creating Market Access strategies is one of the activities that CHARTA has performed for years A valid and well-designed MA strategy is by now an obvious critical successful factor for new technologies, in particular for specialized products and medical devices, in order to make them actually and promptly available for patients that can benefit from them as well as represent a desirable aim for companies that have developed them. The realization of a Market Access plan is not limited to the authorization phase and the following management of prices and reimbursements at central level, but often finds origin already in the phases of design of the clinical Research to continue in the period of marketing with real life studies and database analysis.

The necessary competence for design, development and implementation of the Market Access activities require first of all an important activity on institutional

Affairs, substantialized by the interaction with the interlocutors of healthcare (decision-makers and actuators of healthcare policies) depending on the competence (and evidence) of HTA, Pharmacoeconomics, Outcome Research, P&R developed in an integrated way between them.

The discipline of public procurements is very complex, sometimes contradictory and ever evolving. This often entails increasing difficulties for the Tenders Offices of the Companies in interpreting the standards and rules set by the specifications and conditions of tender for which it is necessary to have a valid consultancy structure supporting the companies during the phases of the tendering process.
The consultancy proposed by CHARTA is, during these phases, not only the provision of a valid legal support to resolve doubts and controversies but also of an assessment, from an economic and opportunity point of view, of the most suitable actions to undertake for the protection of the corporate interests.

To this day, the service of Institutional Monitoring is articulated in the monitoring of topics concerning the pharmaceutical regulatory world in Italy and Europe;

parliamentary activities concerning health, drug; specific national and international areas of interest for the company.

Some examples:

Communications from Aifa;

Publications in Official Gazette of the Italian Republic: determinations and communications on drugs for human use, drugs for veterinary use and pharmaceutical governance;

Communications from Ministry of Health, Superior Institute of Health, EMA, EFPIA, European Commission

Parliamentary activities of Deputies and Senate;

Press Review for specific topics requested by the company.

The Mapping Stakeholders service is conversely articulated in two phases:

Definition clinical area of interest;

Definition research (national or regional)

Activities of

COMMUNICATION

Since its incorporation, CHARTA Foundation has focused, among other activities, on training, continued refresher and ECM courses operating nationwide with a view to treat topics in a way that is always updated and professional to maintain a high professionalism, improve competence and clinical and management skills of every operator working in the healthcare field.

Thanks to the scientific director Lorenzo Giovanni Mantovani, and the experts whom CHARTA Foundation cooperates with, we are able to propose customized courses on the cutting edge and training activities having quality and innovation as prerequisites.

For some years, CHARTA Foundation has also focused on the realization of great events, launch of product, presentations, press conferences and activities of digital communication to meet every necessity of the companies. Every event is customized and made with attention to detail and thanks to the experience gained in this sector we can propose location with characteristics of every type and institutional rooms, manage logistics needs of the attendees and prepare a custom-made budget.

Contattaci

Inviando il messaggio acconsenti al trattamento dei dati personali (decreto legislativo 196 del 30/Giugno/2003)

Not readable? Change text.

Start typing and press Enter to search